Along these lines, AnxA1-deficient mice displayed reduced breast cancer growth and enhanced survival, and it was proposed that AnxA1 binding to FPR2 on macrophages, influencing their polarization and infiltration of solid tumours, would be the underlying cause for enhanced tumour progression [94]. The gene discussed is ANXA1; the disease is neoplasm.